Abstract:OBJECTIVE:To evaluate if the necrotic tumor tissue treated with microwave coagulation therapy (MCT) can sensitize dendritic cell (DCs), and if the sensitized DCs have the specific inhibit effect on tumor cell. METHODS:CT-26 tumor nodules planted percutaneously in BALB/c mice were treated with MCT. The treated tumor tissue was levigated and filtrates and the filtrate obtained was incubated with the DCs from marrow of the BALB/c mice to get sensitized DCs. The shape of the DCs was observed by the microscopy and the electron microscopy respectively and the immune phenotype was detected by flow cytometer. The ability of the DCs to induce proliferation of T cells was measured by (3)H-TdR incorporation assay. The cytotoxicity of CTL activated by the DCs was measured by (51)Cr release assay. The inhibition of the DCs on the growth of CT-26 tumor in the mice was observed. RESULTS:The DCs cultured with the filter from necrotic tissue of CT-26 tumor had the typical shape and immune phenotype of the sensitized DCs. The intensity of the sensitized DCs and the naive DC to stimulate T lymphocyte proliferation at the DC/T of 1:10 was 80 +/- 10 vs 10 +/- 5 (P < 0.01); and at the DC/T of 1:20 was 58 +/- 7 vs 9 +/- 3 (P < 0.01). The killing effect of specific CTLs on CT-26 cancer cells in the sensitized DCs and the naive DCs group were 13.6 +/- 2.5 vs 1.1 +/- 0.4 (P < 0.01) at the E/T of 10:1, 27.5 +/- 4.4 vs 1.4 +/- 0.4 (P < 0.01) at E/T 20:1, and 51.2 +/- 8.1 vs 1.4 +/- 0.5 (P < 0.01) at the E/T of 50:1 respectively. The specific CTL's killing effect on MIP/ND4 lymphoma cells in the sensitized DCs and the naive DCs group were 2.61 +/- 0.64 vs 0.87 +/- 0.15 (P > 0.01) at the E/T of 10:1, 5.22 +/- 0.65 vs 2.18 +/- 0.41 (P > 0.01)at the E/T of 20:1, and 6.09 +/- 0.83 vs 3.91 +/- 0.51 (P > 0.01) at the E/T of 50:1 respectively. The difference of the volumes of the tumor implanted percutaneously in the BALB/c mice became more and more obviously with the prolongation of mice survival times in the sensitized DC group, the naive DC group and the control group. The weight of the tumor at the fortieth day were 4.5 g +/- 1.1 g, 6.9 g +/- 1.6 g, 9.0 g +/- 1.5 g in the three groups respectively (P < 0.01). Finally the special killing effect of the T cells which extracted from the spleen of the mice whose tumor had been treated by the sensitized DCs in vivo and in vitro were observed. CONCLUSION:As an whole cell antigen, the necrotic CT-26 tumor tissue treated with MCT can sensitize DCs, and the sensitized DCs have the specific inhibitory effect on CT-26 tumor cells both in vivo and in vitro.

Anti-cancer effect of cytotoxic T lymphocytes activated by sensitized dendritic cells

Effect of dendritic cells sensitized by tumor cells lysates on the murine breast cancer

Anti-tumor effect of the antigen specific CTLs induced by dendritic cells transfected with total RNA of lung adenocarcinoma cell in vivo

The Study of the Effect of Cytotoxic T Lymphocyte Activated in Vitro by Dendritic Cell Loaded with Tumor Antigens on the Implanted Tumor in Nude Mice

Antigen-loaded dendritic cells and CD40L triggers the killing effects of cytotoxic T lymphocytes on K562 cells in vitro

In vitro anti-tumor effect of cytotoxicity T lymphocytes activated by dendritic cells loaded with freeze-thaw ovarian carcinoma antigen

[The Anti-Tumor Effects of Dendritic Cells Co-Cultured with Cytokine Induced Killer Cells after Chemotherapy].

[Immunotherapy against tumor with dendritic cell sensitized by necrotic tumor tissue after microwave coagulation therapy].

Anti-tumor effect of cytotoxicity T lymphocytes activated by dendritic cells loaded with salivary adenoid cystic carcinoma antigen

Cytotoxic Effects of CTLs Activated by DCs to Kill Autologous Breast Cancer Cells

The anti-tumor immune response of specific cytotoxic T lymphocytes induced by breast cancer stem cells RNA-DCs vaccine

Dendritic cells loaded with apoptotic tumor cells in the treatment of lung cancer

The Effect of Dendritic Cells on the Proliferation and Function of Tumor Specific Cytotoxic T Lymphocyte

In vitro anti-tumor effect of cytotoxic T lymphocyte activated by antigen-loaded dendritic cells from peripheral blood mononuclear cells treated with calcium ionophore A23187 and GM-CSF

Influence of Regulatory T Cells on Antitumor Activity of Dendritic Cells-Cytokine Induced Killer Cells in Gastric Cancer Xenograft Models

Cytotoxic Effect of TGF-β Insensitive Dendritic Cell Vaccine on Cytotoxic T Lymphocytes in Mice with Renal Cell Carcinoma

Research of specific cytotoxic T lymphocytes response on HL60 cells induced by antigen-loaded dendritic cells in vitro

Study on Tumor-Specific Cytotoxicity T Lymphocytes Activated by Dendritic Cells Loaded with Apoptotic Tumor Cells

[Inhibitory effect of dendritic cell vaccine on the growth of implanted tongue squamous cell carcinoma tumors in nude mice].

[Killing Activity of Cytotoxic T Lymphocytes Stimulated by Dendritic Cell Vaccine Loaded with Autologous Cervical Cancer Antigen].

Enhancement of non-MHC restricted anti-tumor effect of immunocytes by dendritic cells